TDN Sponsor Engagement

Effective clinical development plans and good study design can save sponsors and investigators time and money, leading to faster development of potential new therapies for people with cystic fibrosis.

2 min read
In this article

With extensive experience in planning and conducting cystic fibrosis clinical research, the Therapeutics Development Network Coordinating Center (TDNCC) engages with industry sponsors to provide protocol development expertise. This early collaboration and advisement provides support for sponsors prior to the submission of their study protocols to the TDN Scientific Review process.

How It Works

We encourage sponsors to reach out prior to submitting a protocol for formal TDN Scientific Review. This allows our team to provide advisement on how to optimize development plans and study designs so that they are well positioned for conduct in the network.

Getting Started

If you would like to connect with us, please email

Related Information

We also lead and provide scientific study support for CF clinical studies, including overall study management, site monitoring, data management, and biostatistics. The CF Foundation and the CF Therapeutics Development Network have created a position paper addressing trial design strategies for nucleic acid-based therapy programs.

Additionally, we encourage our study sponsors to engage the CF community in their research.

Share this article
Researcher Resources
Engaging the CF Community in Research Download (PDF)
Nucleic Acid-Based Therapy Development Download (PDF)
Have questions? We’re here to help. Call us at 1-800-FIGHT CF

Mon - Thu, 9 am - 5 pm ET
Fri, 9 am - 3 pm ET


More Ways To Get Help